Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Model estimated future health and costs in the risk groups at risk factor levels at the start of KMSP, at 12 months, and the difference (costs in Euro 2012)

From: Heterogeneity in cost-effectiveness of lifestyle counseling for metabolic syndrome risk groups -primary care patients in Sweden

   Men    Women  
  Low Medium High Low Medium High
Lost life-years (YLL)*
start 6.31 6.06 9.62 4.17 7.64 9.49
12 months 6.05 5.75 9.32 3.94 7.36 9.15
difference -0.26 -0.31 -0.30 -0.22 -0.28 -0.35
QALYs
start 13.92 10.79 9.89 12.44 9.95 9.29
12 months 13.97 10.93 10.01 12.53 10.08 9.37
difference 0.05 0.14 0.12 0.09 0.13 0.08
Societal costs
start 56443 52865 70948 48979 69191 71887
12 months 53998 49902 67727 46830 66850 70532
difference -2446 -2963 -3221 -2149 -2341 -1354
Healthcare costs
start 37314 37289 50093 35023 51911 53873
12 months 35616 35738 48232 33727 50612 53114
difference -1698 -1551 -1862 -1295 -1299 -759
  1. * Undiscounted.